1
|
Quadri G, Tomassini F, Rolfo C, Franzè A, Cerrato E, Chinaglia A, Tizzani E, Minniti D, Varbella F. C35 SUCCESSFUL PERCUTANEOUS TREATMENT OF A GIANT CORONARY ANEURYSM IN THE EMERGENCY SETTING. Eur Heart J Suppl 2022. [DOI: 10.1093/eurheartj/suac011.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Abstract
In 2008, a 60–year–old man with an anterior STEMI and cardiogenic shock underwent coronary angiography: a thrombotic occlusion in the mid–LAD, distal to a coronary aneurysm, was successfully treated with DES. (Fig. A). In 2020, the patient was readmitted with NSTE–ACS and cardiogenic shock. The coronary angiography showed severe stenosis after the proximal–LAD aneurysm and occlusion of the previously implanted stent (Fig. B, Panel B1 and B3). A very slow distal coronary flow was provided by a huge epicardial collateral branch emerging from a second giant coronary aneurysm; furthermore, a severe stenosis in the proximal–LCX was present (Fig. B. Panel B1,2). The patient was judged inoperable by the cardiac surgeon. After IABP positioning, a DES was implanted in the LCX. The LAD was then approached. TIMI 3 flow was achieved after a challenging procedure requiring both coronary and peripheral interventional tools: 3 DES (yellow dotted–lines), 8 coronary and 1 peripheral covered stents (green solid–lines) and 6 coils were used to treat the stenosis and exclude the coronary aneurysms. (Fig. B, Panel B3,4). Both DAPT and oral anticoagulation were prescribed at discharge. A 4–month coronary angiography confirmed the good procedural result. (Fig. C). This case shows the unexpected enlargement of a coronary aneurysm through the years and the presence of a new uncommon epicardial communication, necessary to overcome a chronic coronary occlusion. It highlights the importance of knowing different interventional techniques and using non–conventional tools to approach complex coronary anatomies, such as aneurysmatic disease, whose treatment is often challenging, especially in complicated clinical scenarios.
Collapse
Affiliation(s)
- G Quadri
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - F Tomassini
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - C Rolfo
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - A Franzè
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - E Cerrato
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - A Chinaglia
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - E Tizzani
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - D Minniti
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - F Varbella
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| |
Collapse
|
2
|
Meynet I, Quadri G, Tricomi L, Tomassini F, Rolfo C, Franzè A, Zanda G, Piedimonte G, Minniti D, Varbella F. C30 IMPACT OF CORONARY ANATOMY AND RESIDUAL SYNTAX SCORE ON ARRHYTHMIC EVENTS IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY. Eur Heart J Suppl 2022. [DOI: 10.1093/eurheartj/suac011.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
Background
ICD implantation is a cornerstone for primary prevention in patients with ischemic cardiomyopathy and impaired left ventricular function; reduced ejection fraction alone, however, doesn’t seem enough to discriminate which patients will really experience arrhythmic events in the follow up. We hypothesized that coronary anatomy and the extent of residual coronary lesions, measured with syntax score, could be a better predictor of the outcome in this setting.
Materials and Methods
Data of all patients implanted with single or dual chamber ICD in primary prevention for ischemic cardiomyopathy from 2011 to 2020 were retrospectively collected, together with follow up data obtained from clinical visits and ICD remote monitoring. Residual syntax score (RSS) was calculated for each patient, taking into consideration the last coronary angiography performed before ICD implantation.
Results
110 patients were included in our registry. 90.1% were male, mean age was 66±7 years. 23.6% ICD were dual chamber devices. 96 (87.2%), 8 (7.3%) and 6 (5.5%) presented respectively with low (0–22), intermediate (23–32) or high (≥33) RSS. After a mean follow up of 4.4±2.9 years, 31 patients (28.2%) died; 20 patients (18.2%) and 27 patients (24.5%) received any appropriate ICD therapy, either shock or ATP. 12 patients (10.9%) experienced inappropriate shock. The composite outcome of death or any appropriate therapy (MACE) was observed in 47 patients (42.7%); left main or left descending artery stenosis were predictors of MACE (p = 0.026 and p = 0.040 respectively). Intermediate or high RSS was the only predictor of appropriate shock (p = 0.046).
Conclusions
Coronary anatomy and residual coronary stenosis quantified with syntax score are promising predictors of arrhythmic events during the follow up in patients with ischaemic cardiomyopathy and ICD implanted in primary prevention.
Collapse
Affiliation(s)
- I Meynet
- S.C. CARDIOLOGIA, OSPEDALE DI RIVOLI, RIVOLI; S.C. DIREZIONE SANITARIA, OSPEDALE DI RIVOLI, RIVOLI
| | - G Quadri
- S.C. CARDIOLOGIA, OSPEDALE DI RIVOLI, RIVOLI; S.C. DIREZIONE SANITARIA, OSPEDALE DI RIVOLI, RIVOLI
| | - L Tricomi
- S.C. CARDIOLOGIA, OSPEDALE DI RIVOLI, RIVOLI; S.C. DIREZIONE SANITARIA, OSPEDALE DI RIVOLI, RIVOLI
| | - F Tomassini
- S.C. CARDIOLOGIA, OSPEDALE DI RIVOLI, RIVOLI; S.C. DIREZIONE SANITARIA, OSPEDALE DI RIVOLI, RIVOLI
| | - C Rolfo
- S.C. CARDIOLOGIA, OSPEDALE DI RIVOLI, RIVOLI; S.C. DIREZIONE SANITARIA, OSPEDALE DI RIVOLI, RIVOLI
| | - A Franzè
- S.C. CARDIOLOGIA, OSPEDALE DI RIVOLI, RIVOLI; S.C. DIREZIONE SANITARIA, OSPEDALE DI RIVOLI, RIVOLI
| | - G Zanda
- S.C. CARDIOLOGIA, OSPEDALE DI RIVOLI, RIVOLI; S.C. DIREZIONE SANITARIA, OSPEDALE DI RIVOLI, RIVOLI
| | - G Piedimonte
- S.C. CARDIOLOGIA, OSPEDALE DI RIVOLI, RIVOLI; S.C. DIREZIONE SANITARIA, OSPEDALE DI RIVOLI, RIVOLI
| | - D Minniti
- S.C. CARDIOLOGIA, OSPEDALE DI RIVOLI, RIVOLI; S.C. DIREZIONE SANITARIA, OSPEDALE DI RIVOLI, RIVOLI
| | - F Varbella
- S.C. CARDIOLOGIA, OSPEDALE DI RIVOLI, RIVOLI; S.C. DIREZIONE SANITARIA, OSPEDALE DI RIVOLI, RIVOLI
| |
Collapse
|
3
|
Quadri G, Franzè A, Tomassini F, Rolfo C, Meynet I, Celentani D, Gribaudo E, Tizzani E, Cerrato E, Chinaglia A, Lococo M, Palacio S, Minniti D, Varbella F. P67 MAGMARIS FRACTURE AND COLLAPSE DURING PCI: ACUTE TREATMENT AND FOLLOW–UP. Eur Heart J Suppl 2022. [DOI: 10.1093/eurheartj/suac012.065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
Resorbable Magnesium Scaffold (RMS) Magmaris represents an attractive alternative to permanent metal stenting in young patients undergoing PCI. Despite the promising long–term results, especially in terms of scaffold thrombosis, no data on acute RMS deployment failure and subsequent treatment are available. A 44–year–old gentleman with history of effort angina was admitted to our Department to perform coronary angiography. The exam showed an intermediate stenosis in the mid–tract of Left Anterior Descending (LAD, Figure 1, Panel A1), functionally significant (Instantaneous wave–free ratio 0.85). After Optical Coherence Tomography (OCT) evaluation (Panel A2), a wire was placed in Second Diagonal Branch (DG2) and predilation with a NC 3.5mm balloon on mid–tract of LAD was performed, followed by 3.5x25mm Magmaris implantation. Multiple runs performed after removing the jailed guidewire on Dg2, showed a remarkable angiographic result (Panel B1). However, OCT showed struts fracture near the distal RMS segment resulting in scaffold collapse as confirmed by 3D–reconstruction (Panel B2, B3). Therefore, scaffold dilatation with NC 3.5mm balloon was performed, followed by Magmaris 3.5x20mm intra–scaffold implantation. Panel C1 and C2 showed good angiographic and OCT results after postdilatation with NC 3.5 and 4.0mm balloon in the distal and proximal part, respectively. A planned one–year angiography (Panel D1) revealed a small aneurismatic enlargement in the previous overlapped segment, while no residual struts were visible at OCT. (Panel D2) To our knowledge we reported the first case of Magmaris acute fracture (probably due to a forced removal of the Dg2 jailed guidewire) treated with a second intra–scaffold RMS. The present case should emphasize the importance of intracoronary imaging guidance while more data are needed to clarify the optimal treatment of acute RMS implantation failure.
Collapse
Affiliation(s)
- G Quadri
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - A Franzè
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - F Tomassini
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - C Rolfo
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - I Meynet
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - D Celentani
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - E Gribaudo
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - E Tizzani
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - E Cerrato
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - A Chinaglia
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - M Lococo
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - S Palacio
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - D Minniti
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| | - F Varbella
- S.C. CARDIOLOGIA, OSPEDALE DEGLI INFERMI, RIVOLI; S.C. CARDIOLOGIA, AOU SAN LUIGI GONZAGA, ORBASSANO; DIREZIONE MEDICA, ASL TO3, RIVOLI
| |
Collapse
|
4
|
Papadia C, Kelly P, Caini S, Roberto Corazza G, Shawa T, Franzè A, Forbes A, Di Sabatino A. Plasma citrulline as a quantitative biomarker of HIV-associated villous atrophy in a tropical enteropathy population. Clin Nutr 2010; 29:795-800. [DOI: 10.1016/j.clnu.2010.04.008] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2009] [Revised: 03/21/2010] [Accepted: 04/13/2010] [Indexed: 10/19/2022]
|
5
|
Affiliation(s)
- Cinzia Papadia
- Department of Gastroenterology and Clinical Nutrition, Maple House, University College Hospital , 235 Euston Road, London NW1 2BU , UK
| | | | | | | | | | | |
Collapse
|
6
|
Del Rio P, Crafa P, Papadia C, Dell'Abate P, Franzè A, Franzini G, Campanini N, Sianesi M. Evaluation of CD10 positivity in colorectal polyps in neoplastic transformation. Ann Ital Chir 2010; 81:121-127. [PMID: 20726390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
BACKGROUND CD10 is a metalloprotein that is potentially associated with greater tumour growth. MATERIALS AND METHOD We have correlated CD10 positive in carcinomatous polyps with tumour size, grade, patient age and sex, postoperative TNM staging and Asler-Coller classification. We have matched these cases with a control group that showed presence of polypoid adenomatous tissue with mild to moderate dysplasia. RESULTS We have divided these in a group of 39 cases, characterised by the presence of carcinoma arising in adenomatous polyps, and a control group of 16 cases, characterised by the presence of colorectal polyps with mild to moderate dysplasia. In the first group, we have discarded three cases for incomplete data. In the remaining 36 cases we have identified 28 patients testing positive for CD10 with positivity values and 8 cases negative for CD10. In CD10 positive cases, we have confirmed the presence of increased incidence of lymph node involvement compared to CD10 negative cases, with high specificity and high predictive value and a higher incidence of cases attributable to group C (Asler-Coller) and grading 3. CONCLUSIONS CD10 positivity should be assessed in terms of increased progression.
Collapse
Affiliation(s)
- Paolo Del Rio
- Department of Surgical Science, General Surgery and Organ Transplantation, University Hospital of Parma, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
7
|
Cavestro GM, Zuppardo RA, Bertolini S, Sereni G, Frulloni L, Okolicsanyi S, Calzolari C, Singh SK, Sianesi M, Del Rio P, Leandro G, Franzè A, Di Mario F. Connections between genetics and clinical data: Role of MCP-1, CFTR, and SPINK-1 in the setting of acute, acute recurrent, and chronic pancreatitis. Am J Gastroenterol 2010; 105:199-206. [PMID: 19844201 DOI: 10.1038/ajg.2009.611] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
OBJECTIVES Acute, acute recurrent, and chronic pancreatitis are inflammatory diseases with multifactorial pathogenic mechanisms. Genetic mutations and polymorphisms have been correlated with pancreatitis. The aim of this study was to investigate the association of cystic fibrosis transmembrane conductance regulator (CFTR) and serine protease inhibitor Kazal type 1 (SPINK-1) gene mutations and monocyte chemoattractant protein 1 (MCP-1) -2518A/G polymorphism with acute pancreatitis (AP), acute recurrent pancreatitis (ARP), and chronic pancreatitis (CP), and to associate genetic backgrounds with clinical phenotype in these three conditions. METHODS One hundred eighteen AP, 64 ARP, 142 CP patients, and 88 normal controls were enrolled consecutively. We analyzed MCP-1 serum levels using enzyme-linked immunosorbent assay. Polymorphism -2518 of MCP-1 and SPINK-1 N34S gene mutations were determined by PCR-restriction-fragment length polymorphism. Sequence analysis was performed when necessary. Thirty-three CFTR mutations were analyzed in CP and ARP patients using multiplex DNA testing. RESULTS Serum MCP-1 levels were significantly higher in all patients affected by pancreatic inflammatory diseases. Moreover, we found a significant over-representation of the MCP-1G allele in ARP patients. We found a statistically significant association of CFTR gene mutations with ARP, but not with CP. We did not find a statistically significant association of ARP or CP with the N34S SPINK-1 gene mutation. Interestingly, 39 of 64 ARP patients (61%) carried at least one genetic mutation and/or polymorphism. Five of 64 ARP patients had pancreas divisum and four of these five also carried the G allele. CONCLUSIONS Analysis of a comprehensive range of potential susceptibility variants is needed to support modeling of the effects of genes and environment in pancreatitis. As such, beyond gene mutations, the context within which those mutations exist must be considered. In pancreatitis the context includes the inflammatory response, clinical features, and exogenous factors.
Collapse
|
8
|
Coruzzi P, Castiglioni P, Parati G, Brambilla V, Brambilla L, Gualerzi M, Cademartiri F, Franzè A, De Angelis G, Di Rienzo M, Di Mario F. Autonomic cardiovascular regulation in quiescent ulcerative colitis and Crohn's disease. Eur J Clin Invest 2007; 37:964-70. [PMID: 18036030 DOI: 10.1111/j.1365-2362.2007.01887.x] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
BACKGROUND In inflammatory bowel diseases, changes in autonomic enteric regulation may also affect neural cardiovascular control. However, while cardiac autonomic modulation has been shown to be impaired in active ulcerative colitis, the occurrence of cardiovascular autonomic alterations, also in the quiescent phase of inflammatory bowel diseases, is still a matter of debate. The aim of our study was thus to explore the features of cardiovascular autonomic regulation in ulcerative colitis and Crohn's disease during their remission phase. MATERIALS AND METHODS Autonomic cardiovascular control was evaluated by time- and frequency-domain indexes of spontaneous heart rate and blood pressure variability and by assessing the baroreflex heart rate control (sequence technique) in 26 patients with ulcerative colitis, in 26 patients with Crohn's disease and in 23 healthy controls. RESULTS The groups were matched for age, gender and body mass index. They had similar blood pressure mean levels and variability. By contrast, mean heart rate, its overall variability (standard deviation), and baroreflex sensitivity were lower in ulcerative colitis patients than in controls. Moreover, all indexes related to cardiac vagal control were significantly lower in ulcerative colitis patients with respect not only to controls but also to Crohn's disease patients. CONCLUSIONS Cardiac vagal control is impaired in quiescent ulcerative colitis only, and not in Crohn's disease, while in both bowel diseases vascular control appears preserved. Since cardiovagal modulation seems related to anti-inflammatory mechanisms, the reduced parasympathetic cardiac regulation in apparently quiescent ulcerative colitis suggests that such systemic derangement is accompanied by local subclinical inflammations, even in the absence of clinically active inflammatory processes.
Collapse
Affiliation(s)
- P Coruzzi
- University of Parma, Department of Radiology, Azienda Ospedaliero-Universitaria Parma, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Di Mario F, Cavallaro LG, Nouvenne A, Stefani N, Cavestro GM, Iori V, Maino M, Comparato G, Fanigliulo L, Morana E, Pilotto A, Martelli L, Martelli M, Leandro G, Franzè A. A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? Helicobacter 2007; 12:238-43. [PMID: 17493004 DOI: 10.1111/j.1523-5378.2007.00497.x] [Citation(s) in RCA: 80] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
BACKGROUND Curcumin is the principal element of turmeric powder extracted from the root of Curcuma longa. Studies on curcumin have demonstrated some anti-Helicobacter pylori activity as well as immunomodulating properties. N-acetylcysteine and lactoferrin with their respective mucolytic and antibacterial activities might also be effective in H. pylori eradication therapy. AIM To determine if a 7-day non-antibiotic therapy comprised of curcumin, lactoferrin, N-acetylcysteine, and pantoprazole was effective for eradication of H. pylori infection and reduction of gastric inflammation, assessed by serum pepsinogens and relief of symptoms. SUBJECTS AND METHODS Twenty-five consecutive H. pylori-positive patients (12 males, mean age 50 +/- 12 years, range 31-76) with functional dyspepsia were enrolled. Patients were administered for 7 days curcumin 30 mg b.i.d., bovine lactoferrin 100 mg b.i.d., N-acetylcysteine 600 mg b.i.d., and pantoprazole 20 mg b.i.d. H. pylori status and upper gastrointestinal symptoms were assessed by (13)C-urea breath test and a scale of upper gastrointestinal symptoms intensity (absent, mild, moderate, and severe), as well as a blood test for serum pepsinogens (sPGI, sPGII), gastrin-17 (G-17), and anti-H. pylori IgG (IgG-Hp) at baseline (T0) and after 2 months (T1). RESULTS Three of 25 patients (12%) were cured of H. pylori infection. A significant decrease in the overall severity of symptoms (T0: 6, interquartile range [IQR]: 4.5-8; T1: 2, IQR: 2-3; p < or = .001), and sPGII (T0: 16 microg/L, IQR: 13-22; T1: 10 microg/L, IQR: 8-16; p < or = .001) and sPGI (T0: 82 microg/L, IQR: 67-97; T1: 74 microg/L, IQR: 62-94; p = .02) levels were observed after 2 months of the treatment. IgG and G-17 values did not significantly decrease after 2 months. CONCLUSIONS This novel therapy was not effective for H. pylori eradication. However, despite the bacterium persistence, significant improvement of dyspeptic symptoms and reduction of serologic signs of gastric inflammation were observed after 2 months at the end of the 7-day treatment schedule.
Collapse
Affiliation(s)
- Francesco Di Mario
- Section of Gastroenterology, Department of Clinical Sciences, University of Parma, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Abstract
There are few diseases whose incidence varies as greatly worldwide as that of diverticulosis. Its prevalence is largely age-dependent: the disease is uncommon in those under the age of 40, the prevalence of which is estimated at approximately 5%; this increases to 65% in those > or =65 years of age. Of patients with diverticula, 80-85% remain asymptomatic, while, for unknown reasons, only three-fourths of the remaining 15-20% of patients develop symptomatic diverticular disease. Traditional concepts regarding the causes of colonic diverticula include alterations in colonic wall resistance, disordered colonic motility and dietary fiber deficiency. Currently, inflammation has been proposed to play a role in diverticular disease. Goals of therapy in diverticular disease should include improvement of symptoms and prevention of recurrent attacks in symptomatic, uncomplicated diverticular disease, and prevention of the complications of disease such as diverticulitis. Diverticulitis is the most usual clinical complication of diverticular disease, affecting 10-25% of patients with diverticula. Most patients admitted with acute diverticulitis respond to conservative treatment, but 15-30% require surgery. Predictive factors for severe diverticulitis are sex, obesity, immunodeficiency and old age. Surgery for acute complications of diverticular disease of the sigmoid colon carries significant rates of morbidity and mortality, the latter of which occurs predominantly in cases of severe comorbidity. Postoperative mortality and morbidity are to a large extent driven by patient-related factors.
Collapse
|
11
|
Maino M, Mantovani N, Merli R, Cavestro GM, Leandro G, Cavallaro LG, Corrente V, Iori V, Pilotto A, Franzè A, Di Mario F. Effects of chronic therapy with non-steroideal antinflammatory drugs on gastric permeability of sucrose: A study on 71 patients with rheumatoid arthritis. World J Gastroenterol 2006; 12:5017-20. [PMID: 16937498 PMCID: PMC4087405 DOI: 10.3748/wjg.v12.i31.5017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To evaluate the gastric permeability after both acute and chronic use of non-steroidal anti-inflammatory drugs (NSAIDs) and to assess the clinical usefulness of sucrose test in detecting and following NSAIDs- induced gastric damage mainly in asymptomatic patients and the efficacy of a single pantoprazole dose in chronic users.
METHODS: Seventy-one consecutive patients on chronic therapy with NSAIDs were enrolled in the study and divided into groups A and B (group A receiving 40 mg pantoprazole daily, group B only receiving NSAIDs). Sucrose test was performed at baseline and after 2, 4 and 12 wk, respectively. The symptoms in the upper gastrointestinal tract were recorded.
RESULTS: The patients treated with pantoprazole had sucrose excretion under the limit during the entire follow-up period. The patients without gastroprotection had sucrose excretion above the limit after 2 wk, with an increasing trend in the following weeks (P = 0.000). A number of patients in this group revealed a significantly altered gastric permeability although they were asymptomatic during the follow-up period.
CONCLUSION: Sucrose test can be proposed as a valid tool for the clinical evaluation of NSAIDs- induced gastric damage in both acute and chronic therapy. This tecnique helps to identify patients with clinically silent gastric damages. Pantoprazole (40 mg daily) is effective and well tolerated in chronic NSAID users.
Collapse
Affiliation(s)
- Marta Maino
- Department of Clinical Science, University of Parma, Via Gramsci 14, Parma 43100, Italy
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Fanigliulo L, Comparato G, Aragona G, Cavallaro L, Iori V, Maino M, Cavestro GM, Soliani P, Sianesi M, Franzè A, Di Mario F. Role of gut microflora and probiotic effects in the irritable bowel syndrome. Acta Biomed 2006; 77:85-9. [PMID: 17172187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
Abstract
BACKGROUND Even though the cause of irritable bowel sindrome (IBS) is not yet known, alterations of the intestinal microflora may be important in its pathogenesis. AIM To evaluate the efficacy of rifaximine alone or in association with the probiotic strain of Bifidobacterium longum W11 in reducing symptoms in patients with IBS. METHODS We performed a monocentric, prospective, randomized open trial including 70 patients randomized in to two groups: Group A (41 patients) receiving rifaximin 200 (2 cp bid for ten days in a month) followed by a formulation of the probiotic strain of Bifidobacterium longum W11(one granulated suspension for 6 days on alternate weeks ) and Group B (29 patients) receiving only rifaximin 200 (2 cp bid for ten days in a month). The clinical evaluation was performed at admission and after 2-months, taking into account the method of visual analogous. RESULTS At the 2-month follow-up, Group A patients reported a greater improvement of symptoms compared to patients in group B (p = 0.010) even if the physician's opinion at T1 did not confirm these results (p = 0.07). CONCLUSION The increased colonisation by Bifi-dobacterium longum W11, after the cyclic administration of rifaximin, which eradicates the bacterial overgrowth of the small intestine, may reduce symptoms, especially those related to bowel habit and stool frequency in patients with IBS. The abnormalities observed in the colonic flora of IBS suggest, in fact, that a probiotic approach will ultimately be justified.
Collapse
Affiliation(s)
- Libera Fanigliulo
- Chair of Gastroenterology, Department of Clinical Sciences, University of Parma , Italy
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Di Mario F, Aragona G, Dal Bó N, Cavallaro L, Marcon V, Olivieri P, Benedetti E, Orzès N, Marin R, Tafner G, Chilovi F, De Bastiani R, Fedrizzi F, Franceschi M, Salvat MH, Monica F, Piazzi L, Valiante F, Vecchiati U, Cavestro GM, Comparato G, Iori V, Maino M, Leandro G, Pilotto A, Rugge M, Franzè A. Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. Aliment Pharmacol Ther 2006; 23:1235-40. [PMID: 16611285 DOI: 10.1111/j.1365-2036.2006.02851.x] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
BACKGROUND Cure rates for eradication of Helicobacter pylori appear to be decreasing, thus more effective therapies must be identified. AIM To evaluate the efficacy of bovine lactoferrin in the treatment of H. pylori infection. METHODS In a multicentered prospective study, 402 (mean age 52.4, range 19-84 years) H. pylori-positive patients were assigned to one of three regimens: group A - esomeprazole 20 mg b.d., clarithromycin 500 mg b.d. and tinidazole 500 mg b.d. for 7 days; group B - lactoferrin 200 mg b.d. for 7 days followed by the same schedule of group A; group C - esomeprazole 20 mg b.d., clarithromycin 500 mg b.d. and tinidazole 500 mg b.d. plus lactoferrin 200 mg b.d. for 7 days. RESULTS Of the 402 patients, 389 completed the study. Six patients were discontinued due to side effects, one patient in group B died and six patients were lost to follow up. The eradication rate (intention-to-treat analysis) was 77% in group A (105/136), 73% in group B (97/132) and 90% in group C (120/134) (chi(2)-test P < 0.01). The incidence of side effects was 9.5% in group A, 9% in group B and 8.2% in group C (chi(2)-test P = 0.1). CONCLUSION This study demonstrates that bovine lactoferrin is an effective adjuvant to 7-day triple therapy for eradication of H. pylori infection.
Collapse
Affiliation(s)
- F Di Mario
- Gastroenterology, University of Parma, Parma, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Contini S, Corrente V, Nervi G, Franzè A, Scarpignato C. Dysphagia aortica: a neglected symptom of aortoesophageal fistula. Dig Liver Dis 2006; 38:51-4. [PMID: 16321581 DOI: 10.1016/j.dld.2005.03.015] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/11/2005] [Accepted: 03/03/2005] [Indexed: 12/11/2022]
Abstract
Aortoesophageal fistula, secondary to thoracic aortic aneurysm, is an uncommon cause of gastrointestinal bleeding that is uniformly fatal without surgical intervention. Typical symptoms are midthoracic pain and/or dysphagia followed by a usually short, albeit unpredictable, symptom-free interval and by a 'herald' haemorrhage, which is observed in 80% of patients before fatal exsanguinations. Dysphagia is present in 45% of patients, sometimes for several weeks, before the first bleeding occurs. However, dysphagia aortica is rarely considered in the differential diagnosis of dysphagia and lack of awareness, as well as symptom's underevaluation, both contribute to a significant diagnostic and therapeutic delay. We present a case of a 77-year-old woman who died for a bleeding AEF consequent to a thoracic aortic aneurysm and whose main symptom during the past 2 months was dysphagia, which was not taken seriously into consideration by her general practitioner. This case report emphasises that primary care physicians should be alerted to evaluate carefully the alarming symptoms like dysphagia -- especially in elderly patients -- before life threatening complications occur, as they are the ones who could suspect early the diagnosis and make a proper referral.
Collapse
Affiliation(s)
- S Contini
- Department of Surgical Sciences, School of Medicine and Dentistry, University of Parma, Maggiore University Hospital, Via Gramsci 14, Italy.
| | | | | | | | | |
Collapse
|
15
|
Di Mario F, Ingegnoli A, Altavilla N, Cavallaro LG, Bertolini S, Merli R, Cavestro GM, Iori V, Maino M, Leandro G, Franzè A. Influence of antisecretory treatment with proton pump inhibitors on serum pepsinogen I levels. Fundam Clin Pharmacol 2005; 19:497-501. [PMID: 16011738 DOI: 10.1111/j.1472-8206.2005.00348.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
It has been reported in literature that serum pepsinogen levels rise during omeprazole and lansoprazole administration. However, the influence of pantoprazole and esomeprazole on serum pepsinogens levels is still to be assessed. The aim of this study was to evaluate the influence of proton pump inhibitor (PPI) therapy on pepsinogen I (PGI) levels. PGI and gastrin (G17) levels (EIA; Biohit, Helsinki, Finland) in 126 consecutive patients (M 57; F 69, mean age 53, range 15-91), with upper gastrointestinal symptoms at baseline condition and after 2 months of PPI treatment, were evaluated. Patients underwent a therapy schedule based on: omeprazole 20 mg b.i.d. (20 patients), pantoprazole 40 mg b.i.d. (27 patients), esomeprazole 40 mg b.i.d. (29 patients), lansoprazole 30 mg b.i.d. (21 patients) and rabeprazole 20 mg b.i.d. (26 patients) for 2 months. A significant increase in serum PGI (sPGI) levels was found after a 2-month treatment for all five different PPIs: omeprazole, pantoprazole, esomeprazole, lansoprazole and rabeprazole (P < 0.05). The effect of rabeprazole on sPGI was less pronounced as compared with other PPIs, whereas esomeprazole achieved superior sPGI levels, with no overall statistically significant difference among the five groups (P > 0.05). However, a comparison within a single group of PPIs showed a statistical significance when the esomeprazole group was compared with the rabeprazole group (P = 0.007). sPGI levels are significantly influenced by antisecretory therapy, rising under PPI treatment. Moreover, a statistically significant difference in sPGI levels between the rabeprazole and esomeprazole groups has been demonstrated.
Collapse
Affiliation(s)
- Francesco Di Mario
- Chair of Gastroenterology, Department of Clinical Science, University of Parma, Italy
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Cavestro GM, Comparato G, Nouvenne A, Sereni G, Bertolini S, Frulloni L, Dalla Valle R, Soliani P, Zanelli PF, Sianesi M, Franzè A, Di Mario F. Genetics of chronic pancreatitis. JOP 2005; 6:53-9. [PMID: 15650287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Affiliation(s)
- Giulia Martina Cavestro
- Gastroenterology Section, Department of Clinical Sciences, University of Parma. Parma, Italy.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Violi V, Boselli AS, De Bernardinis M, Costi R, Nervi G, Bertelè A, Franzè A, Roncoroni L. Surgical results and functional outcome after total anorectal reconstruction by double graciloplasty supported by external-source electrostimulation and/or implantable pulse generators: an 8-year experience. Int J Colorectal Dis 2004; 19:219-27. [PMID: 14586631 DOI: 10.1007/s00384-003-0528-6] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 07/07/2003] [Indexed: 02/04/2023]
Abstract
BACKGROUND AND AIMS Surgical and functional results after abdominoperineal resection and total anorectal reconstruction by electrostimulated gracilis muscle transposition are still poorly documented. This study prospectively evaluated surgical and functional outcome over time in our patients. PATIENTS AND METHODS Twenty-three patients underwent abdominoperineal resection, coloperineal pullthrough, double graciloplasty, and loop abdominal stoma. Temporary external-source intermittent electrostimulation, biofeedback training, and selective delayed stimulator implantation to improve unsatisfactory results were carried out in the first 13 patients (1st series); thereafter (2nd series) the stimulator was implanted during graciloplasty. Surgical and oncological results were followed up in all patients. Functional results were evaluated in 16 patients who underwent abdominal stoma takedown, eight in each of the two series, by anomanometry (up to 1 year) and our own 0-20 scoring system (up to 8 years from initial surgery). RESULTS The rate of major and minor postoperative complications was 21.7% and 65%, respectively. Continuous electrostimulation proved effective on resting anal pressure. Early clinical assessments showed satisfactory functional results (considered as having a score < or =8) in all first-group patients, including five who had stimulator support, and in one-half of second-group patients. After impairment (at least 2 points) at 1 year in five patients, four of whom were from the first group, all functional results improved and became satisfactory from 5 years on (1st series) and from 4 years on (2nd series). CONCLUSION Despite marked morbidity the high rate of good results, which improved over time, suggests that total anorectal reconstruction is worth being performed as part of abdominoperineal resection in well-selected patients with a strong motivation to avoid a permanent colostomy.
Collapse
Affiliation(s)
- Vincenzo Violi
- Department of Surgical Sciences, General Surgery Clinic, University of Parma Medical School, Via Gramsci 14, 43100 Parma, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
18
|
Di Mario F, Ingegnoli A, Dal Bò N, Cavestro GM, Moussa AM, Cavallaro LG, Aragona G, Iori V, Pilotto A, Franzè A, Rugge M. Early epigastric pain after PPI administration: exacerbation of Helicobacter pylori corpus gastritis? Helicobacter 2004; 9:92-4. [PMID: 15156910 DOI: 10.1111/j.1083-4389.2004.00203.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
19
|
Di Mario F, Moussa AM, Caruana P, Merli R, Cavallaro LG, Cavestro GM, Dal Bò N, Iori V, Pilotto A, Leandro G, Franzè A, Rugge M. 'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection. Scand J Gastroenterol 2003; 38:1223-7. [PMID: 14750641 DOI: 10.1080/00365520310007044] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
BACKGROUND Relatives of patients with gastric cancer are at increased risk of developing this disease, especially if they are infected by Helicobacter pylori. Moreover, H. pylori-related atrophic gastritis and hypochlorhydria are well-documented risk factors for noncardia gastric cancer. Serum pepsinogen I (sPGI) and II (sPGII) levels are low in this condition. The aim of our study was to assess by means of a 'Gastropanel' blood test, including sPGI, sPGII, gastrin-17 (G-17) and antibodies anti-H. pylori (IgG-Hp). both functional and morphological features of gastric mucosa in Hp + ve subjects with a family history of gastric cancer. MATERIALS AND METHODS Twenty-five Hp + ve subjects consecutively referred to our department for gastrointestinal complaints, selected as first-degree relatives of patients suffering from gastric cancer, were enrolled in the study and then matched for sex and age with 25 dyspeptic and Hp + ve subjects with no family history of gastric neoplasia. Blood samples were taken for determination of gastropanel in all patients; in addition, antibodies against CagA were analysed. RESULTS No statistically significant differences were detected between the two groups as regards alcohol consumption, coffee intake and smoking habits. Mean sPGI levels in Group A (83.4 +/- 58.4 microg/L) were significantly lower than those in Group B (sPGI 159.5 +/- 80.6 microg/L; P < 0.0001) as well as sPGII (12.5 microg/L = 6.24 versus 20.6 +/- 58 microg/L; P < 0.006). No statistical difference was found between the two groups in relation to G-17 levels, IgG-Hp titres and antibodies against CagA. CONCLUSION First-degree relatives of patients with noncardia gastric cancer affected by H. pylori infection present lower sPGI and sPGII levels, possibly due to the increased frequency of atrophic lesions in these patients.
Collapse
Affiliation(s)
- F Di Mario
- Dept. of Clinical Science, University of Parma, Parma, Italy.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Cavestro GM, Ingegnoli AV, Aragona G, Iori V, Mantovani N, Altavilla N, Dal Bò N, Pilotto A, Bertelè A, Franzè A, Di Mario F, Borghi L. Lactoferrin: mechanism of action, clinical significance and therapeutic relevance. Acta Biomed 2003; 73:71-3. [PMID: 12643075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
Abstract
Lactoferrin is an iron binding protein involved in a large spectrum of biological actions including antimicrobial actions. Lactoferrin plays a central role in ferrokinetics: it binds free iron with great affinity limiting the amount of ions available for microorganism's metabolism. Its role in the host defence mechanisms consists in bacteriostatic and bactericidal effects; moreover it inhibits the proliferation of other microbes such as fungi and viruses. Lactoferrin is also involved in the modulation of immune system and recent studies indicate that lactoferrin directly modulates both production and function of neutrophils and monocytes.
Collapse
|
21
|
Di Mario F, Aragona G, Dal Bò N, Cavestro GM, Cavallaro L, Iori V, Comparato G, Leandro G, Pilotto A, Franzè A. Use of bovine lactoferrin for Helicobacter pylori eradication. Dig Liver Dis 2003; 35:706-10. [PMID: 14620619 DOI: 10.1016/s1590-8658(03)00409-2] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
BACKGROUND One-week triple therapy is the most frequently recommended treatment for Helicobacter pylori infection. Eradication rate is satisfactory, nevertheless is advisable to look for more effective therapies. AIM To test the efficacy of a standard triple therapy plus bovine lactoferrin in the eradication of H. pylori infection. PATIENTS AND METHODS One hundred and fifty consecutive H. pylori positive patients, suffering from dyspeptic symptoms were recruited in a 7-day triple therapy open randomised single centre study with rabeprazole, clarithromycin, tinidazole, bovine lactoferrin (group A) or rabeprazole, clarithromycin, tinidazole (group B), or a 10-day therapy with rabeprazole, clarithromycin, tinidazole (group C). H. pylori status was assessed 8 weeks after the end of the treatment by means of a 13C-urea breath test or a H. pylori stool antigen-test. RESULTS Eradication rates (intention to treat/per protocol) were: group A (92.2/95.9%), group B (71.2/72.5%) and group C (70.2/75%). The efficacy of triple therapy added with lactoferrin was significantly higher than other two regimens (p=0.01, intention to treat analysis; p=0.005, per protocol analysis). CONCLUSION These results suggest that lactoferrin tested in the present study was effective in curing H. pylori and could be a new agent to assist the antimicrobials in the eradication of the bacterium.
Collapse
|
22
|
Cavestro GM, Frulloni L, Cerati E, Ribeiro LA, Corrente V, Sianesi M, Franzè A, Di Mario F. Progressive familial intrahepatic cholestasis. Acta Biomed 2003; 73:53-6. [PMID: 12596388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
Abstract
Progressive familial intrahepatic cholestasis (PFIC) is a heterogeneous group of autosomal recessive childhood cholestasis of hepatocellular origin. PFIC 1, also known as Byler disease, was first described in Amish kindred. It is characterized by cholestasis often arising in the neonatal period and it leads to death due to liver failure. PFIC 1, like Benign Recurrent Intrahepatic Cholestasis (BRIC) which is the benign form of the same disease, recognizes mutations in the ATP8B1 gene. PFIC 2 disease is clinically similar to PFIC 1 but it has a different gene mutation causing a defect in the Bile Salt Export Pump (BSEP), exclusively expressed in the liver and involved in the canalicular secretion of bile acids. PFIC 3 usually appears later in life and it has a higher risk of portal hypertension, gastrointestinal bleeding and liver failure. This particular form of disease (the only one with high serum values of g-glutamil transpeptidase), is associated to a genetic defect in the class III multidrug resistance protein (MDR). External biliary diversion and ursodeoxycholic acid therapy, should be considered as the initial therapy in these patients, even if liver transplantation still seems to be the only solution for most patients.
Collapse
|
23
|
Di Mario F, Aragona G, Bò ND, Ingegnoli A, Cavestro GM, Moussa AM, Iori V, Leandro G, Pilotto A, Franzè A. Use of lactoferrin for Helicobacter pylori eradication. Preliminary results. J Clin Gastroenterol 2003; 36:396-8. [PMID: 12702979 DOI: 10.1097/00004836-200305000-00006] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
BACKGROUND One-week triple therapy is the most frequently recommended treatment of Helicobacter pylori infection. The associated eradication rate is satisfactory; nevertheless, it is advisable to look for more effective therapies. Our aim was to test the efficacy of a standard triple therapy plus bovine lactoferrin for the eradication of H. pylori infection. STUDY This open, randomized, single-center study was designed to include 150 consecutive H. pylori-positive patients with dyspeptic symptoms and gastritis who received triple therapy with rabeprazole, clarithromycin, and tinidazole plus lactoferrin for 7 days (group A), rabeprazole, clarithromycin, and tinidazole for 7 days (group B), or rabeprazole, clarithromycin, and tinidazole for 10 days (group C). H. pylori status was assessed 8 weeks after the end of treatment by means of the 13C-urea breath test or H. pylori stool antigen test. RESULTS The 7-day treatment including lactoferrin (group A) was successful in 100% (24/24) of the patients. The eradication rates in groups B and C were 76.9% (20/26 patients; 95% CI, 61%-93%) and 70.8% (17/24 patients; 95% CI, 53%-89%), respectively. A significant difference was found between group A and group B (P = 0.023) and group A and group C (P = 0.022). No differences were found between group B and group C (P = 1.00). CONCLUSION These results suggest that lactoferrin could be a new, effective agent when added to antimicrobial therapy for the eradication of H. pylori. This treatment schedule could be proposed for larger trials of H. pylori eradication therapy, focusing on the excellent preliminary cure rate, good compliance to the treatment schedule, and relatively low price of lactoferrin for full treatment.
Collapse
|
24
|
Cavestro GM, Mantovani N, Coruzzi P, Nouvenne A, Marcucci F, Franzè A, Di Mario F, Okolicsanyi L. Hypercalcemia due to ectopic secretion of parathyroid related protein from pancreatic carcinoma: a case report. Acta Biomed 2002; 73:37-40. [PMID: 12233276] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/26/2023]
Abstract
This case is a report of a male, 52 year old, heavy smoker, with a history of about 10 years of alcohol abuse (he quitted in 1993), gastric resection for ulcer (Billroth II 1970), hypoparathyroidism and macroamylasemia, died for undiagnosed pancreatic carcinoma revealed at necroscopy. The only clinical evidence of carcinoma were pulmonary metastasis and paraneoplastic syndrome characterized from hyponatriemia due to inappropriate secretion of antidiuretic hormone and elevation of seric calcium caused by parathyroid hormone related protein. In patients without endocrine abnormalities, such unusual paraneoplastic syndrome could cause hypercalcemia, but in our patient, the increased calcemia did not reach abnormal levels due to the previous hypoparathyroidism. At present time, there are no clinical reports of parathyroid related protein secretion by pancreatic carcinoma and therefore, it could speculate that this modification together with ectopic secretion of antidiuretic hormone, represent a peculiar evidence of otherwise unknown and undetectable pancreatic carcinoma.
Collapse
|
25
|
Nervi G, Ceroni P, Bertelè A, Franzè A. [Multidimensional appraisal in patients suffering from chronic idiopathic constipation]. Acta Biomed Ateneo Parmense 2002; 72:45-54. [PMID: 11554123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
Abstract
A multidimensional appraisal of the patient suffering from chronic idiopatic constipation is used in this study. 16 consecutive patients affected by chronic idiopatic constipation defined by Rome criteria were enrolled. The following assessments were performed: radiological study of colorectal transit time using radiopaque markers, anorectal manometry, proctography, psychiatric appraisal, with the somministration of The Minnesota Multiphasic Personality Inventory 2, Hamilton Rating Scales for Depression, Hamilton Rating Scales for Anxiety, Toronto Alexithymia Scales, quality of life appraisal, by means of Short Form 36. The present study must be considered a pilot-study, lead on a limited champion of 16 cases; the reported data express therefore tendencies. Chronic idiopatic constipation appears to be a disturbance with a strong impact on the patient's quality of life. The study moreover confirms the hypothesis of a multifactorial genesis for chronic idiopatic constipation, in which psychopathological aspects (anxiety, depression and alessitimia in particular) and personality traits play a fundamental role, as much as the physiopathological alterations. Colorectal transit time study and anorectal manometry confirm to be valid instruments for the evaluation of physiopathological characteristics, useful for a classification of patients, particularly with respect to the presence of a normal or slowed colorectal transit and to the relief of pelvic floor dysfunctions. The differences between subgroups based on physiopathological characteristics, with respect to quality of the life and personality traits, expressed as tendency, need a confirm form studies lead on larger champions.
Collapse
Affiliation(s)
- G Nervi
- Divisione di Gastroenterologia ed Endoscopia Digestiva, Az. Ospedaliera Universitaria di Parma.
| | | | | | | |
Collapse
|
26
|
Ciccodicola A, D'Esposito M, Esposito T, Gianfrancesco F, Migliaccio C, Miano MG, Matarazzo MR, Vacca M, Franzè A, Cuccurese M, Cocchia M, Curci A, Terracciano A, Torino A, Cocchia S, Mercadante G, Pannone E, Archidiacono N, Rocchi M, Schlessinger D, D'Urso M. Differentially regulated and evolved genes in the fully sequenced Xq/Yq pseudoautosomal region. Hum Mol Genet 2000; 9:395-401. [PMID: 10655549 DOI: 10.1093/hmg/9.3.395] [Citation(s) in RCA: 73] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Human sex chromosomes, which are morphologically and genetically different, share few regions of homology. Among them, only pseudoautosomal regions (PARs) pair and recombine during meiosis. To better address the complex biology of these regions, we sequenced the telomeric 400 kb of the long arm of the human X chromosome, including 330 kb of the human Xq/YqPAR and the telomere. Sequencing reveals subregions with distinctive regulatory and evolutionary features. The proximal 295 kb contains two genes inactivated on both the inactive X and Y chromosomes [ SYBL1 and a novel homologue ( HSPRY3 ) of Drosophila sprouty ]. The GC-rich distal 35 kb, added in stages and much later in evolution, contains the X/Y expressed gene IL9R and a novel gene, CXYorf1, only 5 kb from the Xq telomere. These properties make Xq/YqPAR a model for studies of region-specific gene inactivation, telomere evolution, and involvement in sex-limited conditions.
Collapse
Affiliation(s)
- A Ciccodicola
- International Institute of Genetics and Biophysics, CNR, Via Marconi 10, 80125 Naples, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Franzè A, Galeazzi R, Marcucci F, Biraghi M. [Topical treatment of ulcerative colitis. Doubleblind study between beclomethasone dipropionate and mesalazine]. MINERVA GASTROENTERO 1999; 45:287-96. [PMID: 16498341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/06/2023]
Abstract
Fifty-nine patients with ulcerative colitis localised in the rectum, sigmoid and colon entered the trial. Thirty were treated with BDP and twenty-nine with 5-Aminosalicylic (enemas and suppositories) for 8 weeks, in a doubleblind, controlled study. Clinical, endoscopic and histological assessment was carried out before and after 4 and 8 weeks of treatment. It is concluded that BDP is a new important treatment for mild and moderate activity ulcerative colitis.
Collapse
Affiliation(s)
- A Franzè
- Divisione di Gastroenterologia ed Endoscopia Digestiva, USSL 4, Parma
| | | | | | | |
Collapse
|
28
|
Prantera C, Cottone M, Pallone F, Annese V, Franzè A, Cerutti R, Bianchi Porro G. Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial. Gastroenterology 1999; 116:521-6. [PMID: 10029609 DOI: 10.1016/s0016-5085(99)70172-1] [Citation(s) in RCA: 85] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
BACKGROUND & AIMS The efficacy of 5-aminosalicylic acid (mesalamine) in the treatment of flare-ups of Crohn's disease is controversial. In previous studies, different locations and pathological behavior of Crohn's disease could have obscured the efficacy of these drugs that deliver their substance in different intestinal sites. The present study tested two different mesalamine formulations with 6-methylprednisolone in mild to moderate active Crohn's ileitis. METHODS Ninety-four patients with Crohn's ileitis (Crohn's Disease Activity Index [CDAI], 180-350) were randomly assigned to receive for 12 weeks mesalamine tablets, 4 g (35 patients); mesalamine microgranular preparation, 4 g (28 patients); and 6-methylprednisolone, 40 mg (31 patients). Mesalamine microgranular preparation was a gelatin capsule containing 400 mg of mesalamine microgranules coated with Eudragit S, which has been shown to deliver the drug in the terminal ileum. RESULTS Patients taking mesalamine tablets experienced a decrease of CDAI median score value of 113.5 (95% confidence interval [CI], 33-149) compared with 123 (95% CI, 77-155) in the mesalamine microgranular group and 154 (95% CI, 99-197) in the 6-methylprednisolone group (P = 0.07 [NS]). Remission at the final visit occurred in 19 of 31 (61%) patients taking steroids compared with 21 of 35 (60%) patients taking mesalamine tablets and 22 of 28 (79%) patients taking microgranular mesalamine (NS). Five patients on steroids were withdrawn because of side effects, and a case of pancreatitis was related to microgranular mesalamine. CONCLUSIONS Mesalamine in microgranular formulation seems to be equally as effective as a standard dosage of steroids in the treatment of the mild to moderate form of Crohn's ileitis.
Collapse
Affiliation(s)
- C Prantera
- Department of Gastroenterology, Ospedale Nuovo Regina Margherita, Rome
| | | | | | | | | | | | | |
Collapse
|
29
|
Franzè A, Ferrante MI, Fusco F, Santoro A, Sanzari E, Martini G, Ursini MV. Molecular anatomy of the human glucose 6-phosphate dehydrogenase core promoter. FEBS Lett 1998; 437:313-8. [PMID: 9824315 DOI: 10.1016/s0014-5793(98)01259-9] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
The gene encoding glucose 6-phosphate dehydrogenase (G6PD), which plays a pivotal role in cell defense against oxidative stress, is ubiquitously expressed at widely different levels in various tissues; moreover, G6PD expression is regulated by a number of stimuli. In this study we have analyzed the molecular anatomy of the G6PD core promoter. Our results indicate that the G6PD promoter is more complex than previously assumed; G6PD expression is under the control of several elements that are all required for correct promoter functioning and, furthermore, a still unidentified mammalian specific factor is needed.
Collapse
Affiliation(s)
- A Franzè
- Istituto Internazionale di Genetica e Biofisica, CNR, Naples, Italy.
| | | | | | | | | | | | | |
Collapse
|
30
|
Rosati M, Marino M, Franzè A, Tramontano A, Grimaldi G. Members of the zinc finger protein gene family sharing a conserved N-terminal module. Nucleic Acids Res 1991; 19:5661-7. [PMID: 1945843 PMCID: PMC328972 DOI: 10.1093/nar/19.20.5661] [Citation(s) in RCA: 63] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
We report the isolation of human members of a sub-family of structurally related finger protein genes. These potentially encode polypeptides containing finger motifs of the Krüppel type at the C-terminus, and a conserved amino acid module at the N-terminus; because of its invariant location the latter is referred to as finger preceding box (FPB). The FPB, detected also in previously described finger proteins from human, mouse and Xenopus, extends over approximately 65 amino acids and appears to be composed of two contiguous modules: FPB-A (residues 1-42) and FPB-B (residues 43-65). The latter is absent in some of the members analyzed. Elements A and B and the zinc finger domain are encoded by separate exons in the ZNF2 gene, a human member of this sub-family. The positioning of introns within this gene is remarkable. One intron flanks and a second interrupts the first codon of the FPB-A and FPB-B modules, respectively. A third intron occurs a few nucleotides downstream of FPB-B marking its separation from the remainder of the coding sequences. This organization, together with the absence of FPB-B in some cDNAs, supports the hypothesis that mRNAs encoding polypeptides that include one, both or none of the FPB-A and FPB-B modules may be assembled through alternative splicing pathways. Northern analyses showed that members of this sub-family are expressed as multiple transcripts in several cell lines. The sequences of distinct cDNAs homologous to the ZNF2 gene indicate that alternative splicing events adjoin either coding or non coding exons to the FPB sequences.
Collapse
Affiliation(s)
- M Rosati
- International Institute of Genetics and Biophysics, Naples, Italy
| | | | | | | | | |
Collapse
|
31
|
Franzè A, Archidiacono N, Rocchi M, Marino M, Grimaldi G. Isolation and expression analysis of a human zinc finger gene (ZNF41) located on the short arm of the X chromosome. Genomics 1991; 9:728-36. [PMID: 2037297 DOI: 10.1016/0888-7543(91)90367-n] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
We have isolated a novel human zinc finger gene, ZNF41, from a human X-chromosome-specific library. Nucleotide sequence analysis reveals that ZNF41 potentially encodes a polypeptide featuring an array of 18 contiguous zinc fingers of the C2H2 type. Multiple polyadenylated transcripts homologous to ZNF41 are present at different levels in several distinct cell types. Southern analyses of somatic cell hybrids containing either intact or rearranged X chromosomes confirm the genomic origin of the isolated gene and establish that it is localized between Xcen and Xp22.1.
Collapse
Affiliation(s)
- A Franzè
- International Institute of Genetics and Biophysics, CNR, Naples, Italy
| | | | | | | | | |
Collapse
|
32
|
Antignani PL, Franzè A. ["Coup de fouet" syndrome]. Clin Ter 1991; 136:283-5. [PMID: 1827392] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Affiliation(s)
- P L Antignani
- Divisione di Angiologia dell'Ospedale S. Camillo, Roma
| | | |
Collapse
|
33
|
Verde P, Boast S, Franzè A, Robbiati F, Blasi F. An upstream enhancer and a negative element in the 5' flanking region of the human urokinase plasminogen activator gene. Nucleic Acids Res 1988; 16:10699-716. [PMID: 3205721 PMCID: PMC338934 DOI: 10.1093/nar/16.22.10699] [Citation(s) in RCA: 92] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
The 5' flanking region of the human urokinase (uPA) gene has been fused to the reporter chloramphenicol acetyl transferase (CAT) gene and its activity assayed by transfection in two human cell lines. Progressive deletions of the uPA regulatory region from the 5' end maintain a high level of expression provided at least 1870 (in A1251 cells) or 1963 (in HFS10 cells) nucleotides of the 5' flanking region are retained. A DNA fragment from -2350 to -1824 has enhancer properties, stimulating transcription of an enhancerless SV40 early promoter independently of orientation and distance. Internal deletions that still retain the enhancer element reveal the presence of negative cis-acting sequences between -1824 and -1572. Their removal, in fact, increases uPA transcriptional activity. Differences of expression of the uPA-CAT fusion genes in the two cell lines are also observed, indicating the presence of cell-specific cis-acting sequences.
Collapse
Affiliation(s)
- P Verde
- International Institute of Genetics and Biophysics, CNR, Naples, Italy
| | | | | | | | | |
Collapse
|
34
|
Tramontano A, Scarlato V, Barni N, Cipollaro M, Franzè A, Macchiato MF, Cascino A. Statistical evaluation of the coding capacity of complementary DNA strands. Nucleic Acids Res 1984; 12:5049-59. [PMID: 6547531 PMCID: PMC318899 DOI: 10.1093/nar/12.12.5049] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Two independent methods are used to evaluate the protein-coding information content in different classes of DNA sequences. The first method allows to evaluate the statistical relevance of finding unidentified reading frames, longer than 100 codons, on both DNA strands of: a) 117 DNA sequences that code for 142 nuclear proteins; b) 39 stable RNA coding sequences and c) 36 other DNA sequences which include regulatory and as yet unknown function sequences. The finding of 50 reading frames longer than 100 codons (complementary inverted proteins or c.i.p. genes) located on the DNA strand complementary to the protein-coding one is drastically in excess of the number predicted by chance alone. An independent method (testcode) applied to c.i.p. gene sequences, which assigns the probability of coding to a given sequence, predicts that more than 50% of these genes are translated in a functional product. These analyses indicate the existence of a new class of protein-coding genes, located on the DNA sequences complementary to the protein-coding DNA strand.
Collapse
|
35
|
Pierno G, Barni N, Candurro M, Cipollaro M, Franzè A, Juliano L, Macchiato MF, Mastrocinque G, Moscatelli C, Scarlato V. Computer programs for the characterization of protein coding genes. Nucleic Acids Res 1984; 12:281-5. [PMID: 6546420 PMCID: PMC321004 DOI: 10.1093/nar/12.1part1.281] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Computer programs, implemented on an Univac II00/80 computer system, for the identification and characterization of protein coding genes and for the analysis of nucleic acid sequences, are described.
Collapse
|